{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T08:52:58Z","timestamp":1758444778201,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.metabol.2004.08.008","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T03:48:09Z","timestamp":1106970489000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fibrinogen and other coronary risk factors"],"prefix":"10.1016","volume":"54","author":[{"given":"Finn Edler","family":"von Eyben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejvind Aae","family":"Mouritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulius","family":"Montvilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Dimcevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge Helleberg","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbeth Langholz","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riel","family":"von Eyben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2004.08.008_bib1","first-page":"S1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"10","author":"De Backer","year":"2003","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.metabol.2004.08.008_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0021-9150(02)00309-X","article-title":"Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study","volume":"266","author":"Scarabin","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2004.08.008_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00043798-200206000-00006","article-title":"Smoking, low density lipoprotein cholesterol, fibrinogen, and acute myocardial infarction before 41 years of age: a Danish case-control study","volume":"9","author":"von Eyben","year":"2002","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.metabol.2004.08.008_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.ATV.11.2.344","article-title":"Plasma fibrinogen and ischemic heart disease risk factors","volume":"11","author":"Moller","year":"1991","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.008_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(91)90167-2","article-title":"Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors","volume":"91","author":"Folsom","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2004.08.008_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.ATV.12.7.780","article-title":"Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990","volume":"12","author":"Krobot","year":"1992","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.008_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.ATV.20.1.271","article-title":"Life style and hemostatic risk factors for ischemic heart disease. The Caerphilly Study","volume":"20","author":"Yarnell","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.008_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0895-4356(94)90298-4","article-title":"Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the North Sweden Monica Study","volume":"47","author":"Eliasson","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.metabol.2004.08.008_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(96)90147-6","article-title":"Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen","volume":"347","author":"Brunner","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2004.08.008_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/ije\/25.3.521","article-title":"Plasma fibrinogen and its correlates in urban Japanese men","volume":"25","author":"Sato","year":"1996","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.metabol.2004.08.008_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0037-1615353","article-title":"Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction","volume":"80","author":"Scarabin","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.metabol.2004.08.008_bib12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0026-0495(94)90020-5","article-title":"Hyperinsulinemia predicts low tissue plasminogen activator inhibitor activity in a healthy population: the Northern Sweden MONICA Study","volume":"43","author":"Eliasson","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2004.08.008_bib13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/diacare.20.8.1252","article-title":"Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects","volume":"20","author":"Eliasson","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2004.08.008_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.ijo.0802309","article-title":"Intra-abdominal obesity and metabolic risk factors: a study of young adults","volume":"27","author":"von Eyben","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"year":"1959","series-title":"Prestige, class, and mobility","author":"Svalastoga","key":"10.1016\/j.metabol.2004.08.008_bib15"},{"year":"1984","series-title":"Social groups in Denmark","author":"Hansen","key":"10.1016\/j.metabol.2004.08.008_bib16"},{"key":"10.1016\/j.metabol.2004.08.008_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of serum low density lipoprotein cholesterol without use of the preparative ultracentrifuge","volume":"18","author":"Friedewall","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.metabol.2004.08.008_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.97.11.1029","article-title":"Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study","volume":"97","author":"Jeppesen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2004.08.008_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"year":"1991","series-title":"Practical statistics for medical research","author":"Altman","key":"10.1016\/j.metabol.2004.08.008_bib20"},{"key":"10.1016\/j.metabol.2004.08.008_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/140174301750101429","article-title":"Smoking and other major coronary risk factors and acute myocardial infarction before 41 years of age\u2014two Danish case control studies","volume":"35","author":"von Eyben","year":"2001","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.metabol.2004.08.008_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1655912","article-title":"Family history of coronary heart disease and hemostatic variables in middle-aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Research Group","volume":"77","author":"Pankow","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.metabol.2004.08.008_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"de Lange","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2004.08.008_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/140349489101900207","article-title":"Social class and cardiovascular risk factors in Danish men","volume":"19","author":"Moller","year":"1991","journal-title":"Scand. J. Soc. Med."},{"key":"10.1016\/j.metabol.2004.08.008_bib25","first-page":"277","article-title":"Socio-economic status, ABO phenotypes and risk of ischaemic heart disease: an 8-years follow-up in the Copenhagen Male Study","volume":"7","author":"Suadicani","year":"2000","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.metabol.2004.08.008_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ije\/30.2.248","article-title":"Socio-economic status and ischaemic heart disease mortality","volume":"30","author":"Suadicani","year":"2001","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.metabol.2004.08.008_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.300.6725.634","article-title":"Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men","volume":"300","author":"Rosengren","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2004.08.008_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0091-7435(03)00010-0","article-title":"Contribution of contemporaneous risk factors to social inequality in coronary heart disease and all causes mortality","volume":"36","author":"Woodward","year":"2003","journal-title":"Prev. Med."},{"key":"10.1016\/j.metabol.2004.08.008_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1749-6632.2001.tb03534.x","article-title":"Transcriptional control mechanism of fibrinogen gene expression","volume":"936","author":"Fuller","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.metabol.2004.08.008_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(83)91849-4","article-title":"Hypertriglyceridaemia and hypercoagulability","volume":"ii","author":"Simpson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2004.08.008_bib31","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jcem.85.3.6555","article-title":"Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects","volume":"85","author":"Fernandez-Real","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.08.008_bib32","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","article-title":"Total cholesterol\/HDL cholesterol ratio vs LDL cholesterol\/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study","volume":"161","author":"Lemieux","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.metabol.2004.08.008_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1055\/s-0038-1649699","article-title":"The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden","volume":"70","author":"Green","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.metabol.2004.08.008_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.93.3.440","article-title":"Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde","volume":"93","author":"Behague","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2004.08.008_bib35","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1172\/JCI119499","article-title":"A common mutation (G\u2212455\u2192A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study","volume":"99","author":"Tybjaerg-Hansen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.metabol.2004.08.008_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.18.2.265","article-title":"\u2212455G\/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for the acute-phase reaction pattern of fibrinogen: REGRESS group","volume":"18","author":"de Maat","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.008_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1047-2797(00)00203-9","article-title":"Beta-fibrinogen gene \u2212455 G\/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) study","volume":"11","author":"Folsom","year":"2001","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.metabol.2004.08.008_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0037-1612940","article-title":"The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise","volume":"87","author":"Brull","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.metabol.2004.08.008_bib39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0895-4356(93)90111-D","article-title":"Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men","volume":"46","author":"Lakka","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.metabol.2004.08.008_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0021-9150(93)90160-V","article-title":"Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women","volume":"102","author":"Rankinen","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2004.08.008_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0038-1646284","article-title":"Reduction in factor VII, fibrinogen, and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity","volume":"68","author":"Primrose","year":"1992","journal-title":"Thromb. Haemost."}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504003269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504003269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:51:58Z","timestamp":1758423118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049504003269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0026049504003269"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2004.08.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrinogen and other coronary risk factors","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2004.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}